Piperazine-substituted benzothiophenes for treatment of mental disorders

Details for Australian Patent Application No. 2006237905 (hide)

Owner Otsuka Pharmaceuticals Co., Ltd.

Inventors Oshima, Kunio; Miyamura, Shin; Yamashita, Junko; Kikuchi, Tetsuro; Takahashi, Haruka; Uwahodo, Yasufumi; Yamashita, Hiroshi; Hashimoto, Kazuya; Mori, Atsushi; Oshiro, Yasuo; Tadori, Yoshihiro; Amada, Naoki; Masumoto, Takumi; Tanaka, Tatsuyoshi; Maeda, Kenji; Akazawa, Hitomi; Shimada, Jun; Ito, Nobuaki; Matsubara, Jun; Kuroda, Hideaki; Shimizu, Satoshi

Agent Davies Collison Cave

Pub. Number AU-B-2006237905

PCT Pub. Number WO2006/112464

Priority 2005-116698 14.04.05 JP

Filing date 12 April 2006

Wipo publication date 26 October 2006

Acceptance publication date 3 September 2009

International Classifications

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

25 October 2007 PCT application entered the National Phase

  PCT publication WO2006/112464 Priority application(s): WO2006/112464

3 September 2009 Application Accepted

  Published as AU-B-2006237905

8 October 2009 Application for Amendment

  The nature of the amendment is: Amend applicant name from Otsuka Pharmaceuticals Co., Ltd. to Otsuka Pharmaceutical Co., Ltd.. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

5 November 2009 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to remove coinventors Oshima, Kunio; Miyamura, Shin; Takahashi, Haruka; Yamashita, Hiroshi; Tanaka, Tatsuyoshi; Ito, Nobuaki; Matsubara, Jun; Kuroda, Hideaki and Shimizu, Satoshi . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2008

28 January 2010 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to delete coinventors Oshiro, Yasuo; Shimada, Jun; Maeda, Kenji; Tadori, Yoshihiro; Amada, Naoki; Akazawa, Hitomi; Yamashita, Junko; Mori, Atsuhi; Uwahodo, Yasufumi; Matsumoto, Takumi; Kikuchi, Tetsuo; Hashimoto, Kazuya . Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

28 January 2010 Amendment Made

  The nature of the amendment is: Amend applicant name from Otsuka Pharmaceuticals Co., Ltd. to Otsuka Pharmaceutical Co., Ltd.

28 January 2010 Corrigenda

  Amendments - Application for Amendments Under the name Otsuka Pharmaceuticals Co., Ltd., Delete all reference to Application No. 2006237905

13 May 2010 Amendment Made

  The nature of the amendment is: Remove Co-inventors Oshiro, Yasuo; Shimada, Jun; Maeda, Kenji; Tadori, Yoshihiro; Amada, Naoki; Akazawa, Hitomi; Yamashita, Junko; Mori, Atsuhi; Uwahodo, Yasufumi; Matsumoto, Takumi; Kikuchi, Tetsuo; Hashimoto, Kazuya

13 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006237920-Nitrogen-containing heterocyclic compound

2006237903-Highly safe intranasally administrable gene vaccines for treating Alzheimer's disease